Skip to content
← Back to this collection

PUBLICATIONS · 26020125

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer or Other Tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Thorac Oncol
Publication date
2015 Jul
First author
Nishio M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Nishio M
      type
      Author
    2. name
      Murakami H
      type
      Author
    3. name
      Horiike A
      type
      Author
    4. name
      Takahashi T
      type
      Author
    5. name
      Hirai F
      type
      Author
    6. name
      Suenaga N
      type
      Author
    7. name
      Tajima T
      type
      Author
    8. name
      Tokushige K
      type
      Author
    9. name
      Ishii M
      type
      Author
    10. name
      Boral A
      type
      Author
    11. name
      Robson M
      type
      Author
    12. name
      Seto T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Nishio M
      type
      Author
    2. name
      Murakami H
      type
      Author
    3. name
      Horiike A
      type
      Author
    4. name
      Takahashi T
      type
      Author
    5. name
      Hirai F
      type
      Author
    6. name
      Suenaga N
      type
      Author
    7. name
      Tajima T
      type
      Author
    8. name
      Tokushige K
      type
      Author
    9. name
      Ishii M
      type
      Author
    10. name
      Boral A
      type
      Author
    11. name
      Robson M
      type
      Author
    12. name
      Seto T
      type
      Author
    bibliography ids
    1. nci-bib-f50e73fe4877050058a0d949
    book metadata
    content sha256
    77ee6a927c6869ead82d996e13f0e6414281fc3c9c56342cdae89e5f5803e8df
    document type
    citation
    dois
    1. 10.1097/JTO.0000000000000566
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26020125
    immutable id
    pubmed:26020125@77ee6a927c6869ead82d996e13f0e6414281fc3c9c56342cdae89e5f5803e8df
    journal
    abbreviation
    J Thorac Oncol
    issn electronic
    1556-1380
    issn print
    1556-0864
    issue
    7
    name
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
    nlm unique id
    101274235
    pages
    1058-66
    volume
    10
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26020125
      provenance
      batch id
      74265f1b641f04cf2d05
      provider
      NCBI PubMed ESummary
      record sha256
      2336d274a1536e1a4701e21a1a687a63d0ece792b17e70081e9596bab53c3e12
      response sha256
      193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
      retrieved at
      2026-09-09T23:47:10.134322+00:00
      publication date
      display
      2015 Jul
      precision
      month
      year
      2015
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26020125/
      title
      Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer or Other Tumors.

      Preserved source evidence · Not medical advice